IP Library Granted Patent US 8,652,543
Granted Patent B2
US 8,652,543 · App. 13/720,187 · Granted Feb 18, 2014

Cosmetic and/or pharmaceutical compositions and their applications

Inventors: André Ulmann (Paris, FR); Jean-Frédéric Laville (Paris, FR)
Assignee: Legacy Healthcare Holding Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,652,543
App. No.
13/720,187
Granted
Feb 18, 2014
Kind
B2
Abstract

Compositions are disclosed containing, as active ingredients, an extract of Allium species, an extract of Citrus species and either an extract of Paullinia species and an extract of Theobroma species, or an extract of Salix species and zinc sulphate, and the method of preparation of these compositions, and cosmetic and/or pharmaceutical application of these compositions.

Claims (11)

1. A method for regulating and/or stabilizing conditions affecting the skin of a subject in need thereof comprising:

administering to the subject a composition comprising from 65% to 93% of an aqueous-alcoholic extract of Allium species, from 5% to 33% of an aqueous-alcoholic extract of Citrus species, from 0.25% to 2.5% of an aqueous-alcoholic extract of Paullinia species, and from 0.25% to 2.5% of an aqueous-alcoholic extract of Theobroma species, wherein the conditions are selected from the group consisting of dermatoses, disorders of cicatrisation, disorders of keratinization, keratotic lesions, and hemorrhoidal pressure.

2. The method of claim 1 , wherein the dermatoses is selected from the group consisting of cutaneous bacterial or viral infections, ageing of the skin, bleaching or whitening of the skin, vitiligo, acrodermatitis, photodermatoses, acne, acne rosacea, lupus erythematosus, sensitive skin, insect stings, oily or dry skin, seborrheic disorders, alopecia, hair loss, psoriasis, parapsoriasis, dyshidrosis, warts, corns, scabies, angular cheilitis, and oedema.

3. The method of claim 1 , wherein the disorders of cicatrisation are selected from the group consisting of ciatrisation of wounds, including in subjects due to suffering from diabetes, burns, blotchiness, Behcet's disease, cutaneous porphyria, and angiomas.

4. The method of claim 1 , wherein the disorders of keratinsation are selected from the group consisting of keratotic lesions, hyperkeratosis, keratoderma, dyskeratosis, Darier's disease, parakeratosis, eczema, neurodermatitis, erythroderma, lichenification, scaly dermatosis, prurigo, keloid, and pustulosis.

5. The method of claim 1 , wherein the Allium species is Allium cepa , the Citrus species is Citrus lemon , the Paullinia species is Paullinia cupana , and the Theobroma species is Theobroma cacao.

6. A method for treating a condition affecting the skin, scalp, or external parts of a body of a subject in need thereof, the method comprising:

administering to the subject one to three times a day a composition comprising from 65% to 93% of an aqueous-alcoholic extract of Allium species, from 5% to 33% of an aqueous-alcoholic extract of Citrus species, from 0.25% to 2.5% of an aqueous-alcoholic extract of Paullinia species, and from 0.25% to 2.5% of an aqueous-alcoholic extract of Theobroma species; wherein the condition is selected from a group consisting of dermatosis due to cutaneous bacterial or viral infections, ageing of the skin, bleaching or whitening of the skin, vitiligo, acrodermatitis, photodermatosis, acne, acne rosacea, inflammatory acne, lupus erythematosus, sensitive skin, insect stings, oily or dry skin, seborrheic disorders, alopecia, hair loss, pityriasis capitis, pelada, sensitive scalp, greasy hair, psoriasis of the scalp, parapsoriasis of the scalp, dyshidrosis, warts, corns, scabies, angular cheilitis, oedema, nail disorders, disorders of cicatrisation, disorders of keratinization, keratotic lesions, burns, blotchiness, Behcet's disease, cutaneous porphyria, angiomas, hyperkeratosis, keratoderma, dyskeratosis, Darier's disease, parakeratosis, ichthyosis, eczema, neurodermatitis, erythroderma, lichenification, scaly dermatosis, prurigo, keloid, pustulosis, hemorrhoid pressure, and combinations thereof.

7. The method of claim 6 , wherein the Allium species is Allium cepa , the Citrus species is Citrus lemon , the Paullinia species is Paullinia cupana , and the Theobroma species is Theobroma cacao.

8. The method of claim 6 , wherein the composition is administered to the subject at a daily dose of about 5 to 500 mg.

9. The method of claim 6 , wherein the composition is administered to the subject at a daily dose of about 0.05 mg/kg to 10 mg/kg.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2020
From: LEGACY HEALTHCARE LTD
To: LEGACY HEALTHCARE (SWITZERLAND) SA
Reel/Frame 054413/0762 →
CHANGE OF NAME Recorded Nov 19, 2020
From: LEGACY HEALTHCARE HOLDING LTD
To: LEGACY HEALTHCARE LTD
Reel/Frame 054476/0484 →
Priority Claims (1)
FR 07 01011 · Feb 13, 2007 · national
Continuity (2)
Continuation 12526493
Related Publication 20130108719A1 · May 2, 2013